PURPOSE: Observational studies have investigated the comparative safety of antipsychotics with varying results. Instrumental variable analysis has been suggested as a possible alternative to conventional analyses when there is concern about the effect of unmeasured confounding in observational studies. Using the example of the risk of death with typical compared to atypical antipsychotics, we aimed to explore the performance of two different instruments. We used the doctor prescribing preference instrument, which has been used in previous studies, to investigate further the assumptions of this instrument in the Australian population. We also propose an alternative instrument, nursing home facility preference. METHODS: With the Australian Department of Veterans' Affairs administrative claims database, we used an instrumental variable analysis to compare the risk of death after 12 months between the two antipsychotic classes. RESULTS: Using the doctor prescribing preference instrument we estimated that typical antipsychotics were associated with an extra 24 (95% Confidence Interval (CI) 18-30) deaths per 100 patients per year compared to atypical antipsychotics, and an extra 10 (95% CI 7-14) deaths per 100 patients per year among nursing home residents. Facility prescribing preference was a stronger instrument (OR=19.2 95% CI 17.1-21.6) and provided a better balance of covariates than doctor prescribing preference. CONCLUSIONS: Our study has shown that valid instruments in one population may not be directly applicable to other health care settings and testing of assumptions is crucial when performing IV analyses. Facility prescribing preference appears to be a potentially valid instrument for further work in this area. (c) 2010 John Wiley & Sons, Ltd.
PURPOSE: Observational studies have investigated the comparative safety of antipsychotics with varying results. Instrumental variable analysis has been suggested as a possible alternative to conventional analyses when there is concern about the effect of unmeasured confounding in observational studies. Using the example of the risk of death with typical compared to atypical antipsychotics, we aimed to explore the performance of two different instruments. We used the doctor prescribing preference instrument, which has been used in previous studies, to investigate further the assumptions of this instrument in the Australian population. We also propose an alternative instrument, nursing home facility preference. METHODS: With the Australian Department of Veterans' Affairs administrative claims database, we used an instrumental variable analysis to compare the risk of death after 12 months between the two antipsychotic classes. RESULTS: Using the doctor prescribing preference instrument we estimated that typical antipsychotics were associated with an extra 24 (95% Confidence Interval (CI) 18-30) deaths per 100 patients per year compared to atypical antipsychotics, and an extra 10 (95% CI 7-14) deaths per 100 patients per year among nursing home residents. Facility prescribing preference was a stronger instrument (OR=19.2 95% CI 17.1-21.6) and provided a better balance of covariates than doctor prescribing preference. CONCLUSIONS: Our study has shown that valid instruments in one population may not be directly applicable to other health care settings and testing of assumptions is crucial when performing IV analyses. Facility prescribing preference appears to be a potentially valid instrument for further work in this area. (c) 2010 John Wiley & Sons, Ltd.
Authors: Krista F Huybrechts; Tobias Gerhard; Jessica M Franklin; Raisa Levin; Stephen Crystal; Sebastian Schneeweiss Journal: Pharmacoepidemiol Drug Saf Date: 2014-03-24 Impact factor: 2.890
Authors: Elizabeth E Roughead; Lisa M Kalisch Ellett; Emmae N Ramsay; Nicole L Pratt; John D Barratt; Vanessa T LeBlanc; Philip Ryan; Robert Peck; Graeme Killer; Andrew L Gilbert Journal: BMC Health Serv Res Date: 2013-12-12 Impact factor: 2.655
Authors: Sam Kosari; Jane Koerner; Mark Naunton; Gregory M Peterson; Ibrahim Haider; Emily Lancsar; David Wright; Theo Niyonsenga; Rachel Davey Journal: Trials Date: 2021-06-11 Impact factor: 2.279